Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Pulsoni
The Braf Inhibitor Vemurafenib Plus Rituximab Produces a High Rate of Deep and Durable Responses in Relapsed/Refractory Hairy Cell Leukemia: Updated Results of a Phase-2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease (Mrd) in Early Stage Follicular Lymphoma Can Predict Prognosis and Drive Rituximab Treatment After Radiotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
